News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Press Releases

​​​​​​​Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer

DGAP-News: Epigenomics AG / Key word(s): Personnel18.11.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer Dr. Andrew Lukowiak is a proven senior executive with deep technology and development expertise Appointment underscores Epigenomics’ commitment to the […]

Read more

Epigenomics AG publishes financial results for the first nine months 2021

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results10.11.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for the first nine months 2021 Berlin (Germany) and San Diego, CA (U.S.A.), November 10, 2021 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the “Company”) today […]

Read more

Epigenomics AG: EVP of Finance Albert Weber leaves the Company

DGAP-News: Epigenomics AG / Key word(s): Personnel07.10.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG: EVP of Finance Albert Weber leaves the Company Berlin (Germany) and San Diego, CA (U.S.A.), October 7, 2021 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) announces that Executive Vice […]

Read more

Epigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 million

DGAP-News: Epigenomics AG / Key word(s): Bond/Issue of Debt13.09.2021 / 13:24 The issuer is solely responsible for the content of this announcement. NOT TO BE PUBLISHED, DISSEMINATED OR PASSED ON TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA AND SOUTH AFRICA Press Release Epigenomics AG places maximum number of mandatory convertible bonds […]

Read more

​​​​​​​New study in the BMC Cancer journal shows that Epi proColon(R) is an effective method to increase CRC screening rates in medically underserved populations

DGAP-News: Epigenomics AG / Key word(s): Study results/Study02.09.2021 / 13:42 The issuer is solely responsible for the content of this announcement. New study in the BMC Cancer journal shows that Epi proColon(R) is an effective method to increase CRC screening rates in medically underserved populations The availability of blood based mSEPT9 tests, such as Epi […]

Read more

Epigenomics AG: Securities prospectus for the issuance of a mandatory convertible bond in the amount of up to EUR 16.5 million approved by BaFin

DGAP-News: Epigenomics AG / Key word(s): Issue of Debt/Corporate Action24.08.2021 / 16:16 The issuer is solely responsible for the content of this announcement. NOT TO BE PUBLISHED, DISSEMINATED OR PASSED ON TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA AND SOUTH AFRICA Press Release / Advertising Epigenomics AG: Securities prospectus for the […]

Read more